Searchable abstracts of presentations at key conferences in endocrinology

ea0081ep85 | Adrenal and Cardiovascular Endocrinology | ECE2022

Assessment of glucolipid metabolism in patients with Cushing’s syndrome caused by adrenal adenoma

Li Jie , Zhang Jiaxin , Yang Guimei , Hou Xintong , Yang Dan , Yang Jing , Zhang Yi , Liu Yunfeng

Backgrounds: Based on anthropometry and blood biochemical tests, this study aims to analyze the variation of glucose and lipid metabolism in Cushing’s syndrome (CS) patients caused by adrenal adenoma combining with flash glucose monitoring system (FGMS) and dual-energy X-ray absorptiometry (DEXA).Methods: According to the strict diagnostic and exclusion criteria, seven healthy controls (HCs) and seven CS patients were collected in this study. First,...

ea0073aep60 | Adrenal and Cardiovascular Endocrinology | ECE2021

Assessment of glucolipid metabolism in patients with nonfunctional adrenal incidentaloma

Li Jie , Zhang Jiaxin , Yang Guimei , Hou Xintong , Yang Dan , Yang Jing , Zhang Yi , Liu Yunfeng

BackgroundsThe study aimed to explore the characteristics of glucolipid metabolism in patients with nonfunctional adrenal incidentaloma(NFAI). And investigate the relationship between these factors and insulin resistance, islet beta cell function.MethodsThis study enrolled eight patients with nonfunctional adrenal incidentaloma and five healthy controls(HCs). These data were recorded including body measuremen...

ea0073aep266 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

To assess the glucose metabolism using the flash glucose monitoring system (FGMS) in patients with hormone replacement therapy for hypopituitarism

Jiaxin Zhang1 , Qiong He1 , Minmin Han1 , Jie Li1 , Dan Yang1 , Xintong Hou1 , Guimei Yang1 , Jing Yang1 , Yunfeng Liu1 , Yi Zhang2

BackgroundHormone replacement therapy is often used for hypopituitarism, which leads to dysglycemia. This study is conducted to assess the glucose metabolism conditions using the flash glucose monitoring system (FGMS) in patients with hormone replacement therapy.MethodSeven patients who were diagnosed as hypopituitarism and treated with glucocorticoids and L-Thyroxine were qualified to participate in this stu...

ea0092ps1-06-02 | Thyroid Cancer clinical 1 | ETA2023

Long-Term outcomes following initial therapy in differentiated thyroid cancer (DTC) in china: DTCC 2nd stage study analysis 2014-2022

Ming Jie , Zhu Jing-Qiang , Sun Hui , Zhang Hao , Wang Jun , Xie Lei , Cheng Ruo-Chuan , Li Xing-Rui , Huang Tao

Objectives: We previously reported the outcome of 1-year follow-up of 2013 DTC patients in the DTCC (differentiated thyroid cancer in China) 1st stage Study. Using the retrospectively gathered information, we sought to observe the long-term follow-up and prognosis of these patients with DTC undergoing thyroid surgery.Methods: This multicenter, noninterventional study was conducted at eight tertiary hospitals across China. Data from the patient...

ea0034p167 | Neoplasia, cancer and late effects | SFEBES2014

Calycosin suppresses breast cancer cell growth via ERβ-mediated inhibition of IGF1R pathway

Chen Jian , Tian Jing

We previously reported that calycosin, a natural phytoestrogen structurally similar to estrogen, successfully triggered apoptosis of ER-positive breast cancer cell line, MCF-7. To better understand the antitumor activities of calycosin against breast cancer, besides MCF-7 cells, another ER-positive cell line T-47D was analyzed here, with ER-negative cell lines (MDA-231 and MDA-435) as control. Notably, calycosin led to inhibited cell viability and apoptosis only in ER-positive...

ea0014oc9.2 | Signal transduction | ECE2007

The human orexin receptor type 2 gene: Alternative promoters determining tissue-specific expression and identification of alternate splice variants and altered translational activities

Chen Jing , Randeva Harpal

Orexins, acting via their receptors, are involved in the control of feeding, sleep-wakefulness, arousal, neuroendocrine homeostasis and autonomic regulation. However, the 5′ structure and regulation of human orexin type 2 receptor (OX2R) gene remains is not known. We present original findings regarding the 5′ structural organization of the human OX2R gene and identify four OX2R mRNA transcripts that differ in their 5′-untranslated region (UTR). The four trans...

ea0013p177 | Diabetes, metabolism and cardiovascular | SFEBES2007

The human orexin receptor type 2 gene: Alternative promoters determining tissue-specific expression and identification of alternate splice variants and altered translational activities

Chen Jing , Randeva Harpal

Orexins, acting via their receptors, are involved in the control of feeding, sleep-wakefulness, arousal, neuroendocrine homeostasis and autonomic regulation. However, the 5′ structure and regulation of human orexin type 2 receptor (OX2R) gene remains is not known. We present original findings regarding the 5′ structural organization of the human OX2R gene and identify four OX2R mRNA transcripts that differ in their 5′-untranslated region (UTR). The four trans...

ea0073aep414 | General Endocrinology | ECE2021

Menopausal hormone therapy and women’s health: an umbrella review of systematic reviews and meta-analyses of randomized controlled trials and observational epidemiological studies

Guo-Qiang Zhang , Jin-Liang Chen , Luo Ying , Mathur Maya B. , Anagnostis Panagiotis , Nurmatov Ulugbek , Talibov Madar , Zhang Jing , Hawrylowicz Catherine M. , Lumsden Mary Ann , Critchley Hilary , Sheikh Aziz , Bo Lundbäck , Cecilia Lässer , Kankaanranta Hannu , Lee Siew Hwa , Nwaru Bright I.

ImportanceThere remains uncertainty about the impact of menopausal hormone therapy (MHT) on women’s health. A systematic, comprehensive assessment of the effects on multiple outcomes is lacking.ObjectiveTo comprehensively summarize evidence on the benefits and harms of MHT across diverse health outcomes in women.Data sourcesMEDLINE, EMBASE and 10 other databa...

ea0031oc1.2 | Young Endocrinologists prize session | SFEBES2013

Macrophage-specific 11β-hydroxysteroid dehydrogenase type 1 deficiency promotes angiogenesis but impairs resolution of K/BxN serum induced arthritis

Zhang Zhenguang , Coutinho Agnes , Hadoke Patrick , Salter Donald , Seckl Jonathan , Chapman Karen

Chronic inflammatory disease is often accompanied by angiogenesis and fibrosis. Glucocorticoids (GCs) exert anti-inflammatory and anti-angiogenic effects, in which macrophages are a major target. Local endogenous GC action is controlled by 11β-hydroxysteroid dehydrogenase (11β-HSD), with the type 1 isozyme, 11β-HSD1 converting inactive GCs into active forms. Mice deficient in 11β-HSD1 have a phenotype consistent with reduced glucocorticoid action, including...

ea0081ep7 | Adrenal and Cardiovascular Endocrinology | ECE2022

A phase III trial of recombinant human growth hormone in pediatric patients with growth failure caused by chronic kidney disease

Xu Hong , Tang Xiaoshan , Shen Qian , Chen Jing , Fang Xiaoyan , Zhang Aihua , Zhao Fei , Chen Qiuxia , Huang Wenyan , Wang Ping , Sun Liwen , Xiao Huijie , Xu Ke , Liu Xiaorong , Chen Zhi , Chen Chaoying , Tu Juan , Wu Yubing , Wang Xiuli , Mao Jianhua , Lu Zhihong , Wang Jingjing , Nie Xiaojing , Yu Zihua , Huang Jun , Liu Cuihua , Cao Guanghai , Li Yufeng , Zhu Yaju , Zhang Jianjiang , Wang Miao , Wang Mo , Yang Haiping

Background and objective: Children with chronic kidney disease (CKD) have impaired growth that leads to short stature in adulthood and treatment with recombinant human growth hormone (rhGH) is associated with improved growth. This study aimed to evaluate the efficacy and safety of daily rhGH (Jintropin®) in children in China with growth failure caused by CKD prior to transplantation.Methods: Prepubertal patients (2–13 years old) with CKD-relate...